• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗接种的风险效益和成本效益分析方法。

Methods for risk-benefit and cost-benefit analysis of vaccinations.

作者信息

Wiedermann G, Ambrosch F

出版信息

Dev Biol Stand. 1979;43:429-32.

PMID:118070
Abstract

The basic aim of vaccination is to prevent more severe complications of the respective disease than might be caused by the vaccine itself. Following this idea formulae were developed for calculation of the risk ratio Q and the risk difference D. The following parameters are considered in this formulae: risk of the disease (R), risk of vaccination (r), protection rate (p) and duration of protection (t). Besides, for calculations with partially vaccinated populations the immunization rate "I" has to be considered. A vaccination is beneficial if Q greater than 1.0 and D greater than 0. If vaccinations have proved to be valuable from the medical point of view, additional cost-benefit calculations may be of great importance for socio-economic considerations. Consequently, the above mentioned formulae were modified for calculation of the benefit cost ratio (Qc) and the benefit cost difference (Dc) for monovalent as well as for bivalent vaccines.

摘要

疫苗接种的基本目的是预防相应疾病比疫苗本身可能引起的更严重的并发症。遵循这一理念,制定了用于计算风险比Q和风险差D的公式。这些公式中考虑了以下参数:疾病风险(R)、疫苗接种风险(r)、保护率(p)和保护持续时间(t)。此外,对于部分接种人群的计算,必须考虑免疫率“I”。如果Q大于1.0且D大于0,则疫苗接种是有益的。如果从医学角度证明疫苗接种是有价值的,那么额外的成本效益计算对于社会经济考虑可能非常重要。因此,对上述公式进行了修改,以计算单价和双价疫苗的效益成本比(Qc)和效益成本差(Dc)。

相似文献

1
Methods for risk-benefit and cost-benefit analysis of vaccinations.疫苗接种的风险效益和成本效益分析方法。
Dev Biol Stand. 1979;43:429-32.
2
[Modern trends in vaccination policy: evaluation of benefits, risks and cost (author's transl)].疫苗接种政策的现代趋势:效益、风险及成本评估(作者译)
Wien Klin Wochenschr. 1979 Mar 2;91(5):143-50.
3
[Assessment of efficacy and economic impact of an influenza vaccination campaign in the personnel of a health care setting].[医疗机构人员流感疫苗接种活动的效果及经济影响评估]
Med Lav. 2005 Nov-Dec;96(6):483-9.
4
[Trendobservation of beneficial effects of vaccinations (author's transl)].
Zentralbl Bakteriol Orig A. 1977 Dec;239(4):541-7.
5
[Costs and benefits of measles vaccination].[麻疹疫苗接种的成本与效益]
Fortschr Med. 1978 Feb 23;96(8):409-14.
6
Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.改善供水和霍乱疫苗接种计划投资的成本效益比较。
Vaccine. 2009 May 18;27(23):3109-20. doi: 10.1016/j.vaccine.2009.02.104. Epub 2009 Mar 10.
7
[Anti-influenza vaccination for active persons (25-64 years): a cost-benefit study].[针对活跃人群(25 - 64岁)的抗流感疫苗接种:一项成本效益研究]
Rev Epidemiol Sante Publique. 1992;40(5):285-95.
8
Cost-benefit analysis of hepatitis B vaccination.
Postgrad Med J. 1987;63 Suppl 2:27-32.
9
[Changes in the benefit of immunization].
Fortschr Med. 1977 Jan 20;95(3):159-62.
10
[Cost-benefit ratio of tick-borne encephalitis vaccination of French troops based in Kosovo].
Rev Epidemiol Sante Publique. 2001 Jun;49(3):249-57.